» Environment » Permalink » Source ↑ 0 ↓ Lilly seeks FDA approval for its GLP-1 weight loss pill Elli Lilly has filed for FDA approval of its oral GLP-1 therapy, orforglipron, after another successful phase 3 study.
No comments yet.